LLY vs BMY
Eli Lilly and Company vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | LLY | BMY |
|---|---|---|
| AI Score | 61 | 71 |
| Price | $1,216.24 | $57.52 |
| P/E Ratio | 45.75× | 19.93× |
| ROE | 101.3% | 41.6% |
| Revenue Growth YoY | 47.4% | 1.8% |
| Gross Margin | 82.8% | 53.7% |
| Debt / Equity | 1.60× | 2.44× |
| Dividend Yield | 0.6% | 4.3% |
| RSI (14) | 69.6 | 56.0 |
| Beta | 0.5016 | 0.235 |
| Expected Upside | — | +4.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LLY Full Analysis
BMY Full Analysis